Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patients
Chuang, W.-L., Jia, J., Chan, H. L. Y., Han, K.-H., Tanwandee, T., Tan, D., Chen, X., Gane, E., Piratvisuth, T., Chen, L., Xie, Q., Sung, J. J.-Y., Messinger, D., Wat, C., Bakalos, G., Liaw, Y. F.Language:
english
Journal:
Alimentary Pharmacology & Therapeutics
DOI:
10.1111/apt.14595
Date:
March, 2018
File:
PDF, 896 KB
english, 2018